Skip to page content
MidLantic Urology
Quick Links
  • Pay Bill
  • Patient Portal
  • Appointments
  • News Hub
Main Navigation
MidLantic Urology
Main Links
  • Home
  • About Us
  • Providers
  • Locations
  • Conditions
  • Surgery Center
  • Radiation Oncology Centers
  • Clinical Research
  • Patient Resources
  • Covid-19 Update
Find Your Provider Find Your Location
Quick Links
  • Pay Bill
  • Patient Portal
  • Appointments
  • News Hub
Page Content
Former Philly Mayor Michael Nutter had surgery for prostate cancer. He especially wants Black men to hear about his experience.
June 8, 2021

In December, after more than four years of medical monitoring while keeping his early-stage prostate cancer secret from his family, Michael Nutter had the walnut-size organ removed.

Now, fully recovered — fully, he stressed — the former Philadelphia mayor is advocating that men undergo regular screening for prostate cancer with the PSA blood test.

“Get screened!” he said during an interview on Thursday at the Center City offices of public relations executive Jay Devine. “All you have to do is give a little blood. See where you are. It’s not like they’re drilling a hole in your head.”

Nutter, 63, is aware that prostate specific antigen (PSA) screening is far more controversial than when he began doing it at age 50 in 2008. Back then, his doctor (who is also his best friend from high school) recommended checking his PSA level, so Nutter did it.

Fast forward to today. All the expert groups that issue guidelines, including the American Urological Association, acknowledge a dilemma. Studies show automatic, one-size fits all screening saves very few lives, and leads to diagnosis and treatment of many cancers that would never cause harm if left undetected. Treatment may cause permanent urinary or sexual problems, or both. The guidelines say men should be informed of the risks, as well as the benefits, before deciding what to do.

Nonetheless, Nutter believes he has an “obligation” to encourage PSA screening because of his race. Black men are about 60% more likely to develop prostate cancer during their lives, and twice as likely to die of it than white men. In terms of individual risk, 1 in 6 Black men and 1 in 8 white men are diagnosed; 1 in 23 Black men and 1 in 42 white men die of the disease.

Click here to read the full story featuring MidLantic Urology's Dr. Laurence Belkoff and Dr. David McGinnis from The Philadelphia Inquirer.

MidLantic Urology An affiliate of Solaris Health - a new day in healthcare
Quick Links
  • Pay Bill
  • Patient Portal
  • Appointments
Search Links
  • Find a Doctor
  • Find a Location
Main Links
  • Home
  • About Us
  • Providers
  • Locations
  • Conditions
  • Surgery Center
  • Radiation Oncology Centers
  • Clinical Research
  • Patient Resources
  • Covid-19 Update
Follow Us
  • Facebook
  • LinkedIn
  • Twitter
© Copyright 2022 MidLantic Urology LLC
Billing Disclosures
Site by Piszko